Profile
Caroline J.
Loew worked at Bristol Myers Squibb Co. as Vice President & Head-Research from 2015 to 2018.
From 2018 to 2022, Dr. Loew was President, Chief Executive Officer & Director at Glympse Bio, Inc. Dr. Loew served as Director at Mural Oncology Plc in 2023.
Dr. Loew completed undergraduate and doctorate degrees at Imperial College London.
Former positions of Caroline Loew
| Companies | Position | End |
|---|---|---|
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Develops protein based diagnostic tests that detect and diagnose Alzheimer's disease | Chief Executive Officer | 01/08/2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/10/2018 |
Training of Caroline Loew
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Develops protein based diagnostic tests that detect and diagnose Alzheimer's disease | Health Technology |
- Stock Market
- Insiders
- Caroline Loew
















